Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03355755 · ClinicalTrials.gov registry record · NA
Exoskeleton Treatment of Deconditioning Due to Limited Ambulation Caused by Illness or Injury
A NA study, sponsored by Ekso Bionics.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03355755: Completed NA study, sponsored by Ekso Bionics.
NCT03355755 is a NA study that has completed, run by Ekso Bionics. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03355755, a NA study, has completed, sponsored by Ekso Bionics.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
A safety and feasibility study of robotic exoskeleton training in deconditioned patients residing in a healthcare facility.
Primary Outcome
The primary endpoint is safety defined as the number of participants experiencing an adverse event per overall during the study period.
Interventions
- DEVICE EksoGT with SmartAssist software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-10-11 |
| Est. Completion | 2018-12-13 |
| Phase | NA |
What the finished NCT03355755 record still lists
NCT03355755 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which EksoGT with SmartAssist software is the first listed.
NCT03355755 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03355755 about?
NCT03355755 is a clinical study titled "Exoskeleton Treatment of Deconditioning Due to Limited Ambulation Caused by Illness or Injury". A safety and feasibility study of robotic exoskeleton training in deconditioned patients residing in a healthcare facility.
What is the current status of trial NCT03355755?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2017-10-11. Estimated completion is 2018-12-13.
What interventions are being tested in trial NCT03355755?
The interventions under investigation include: EksoGT with SmartAssist software (DEVICE).
Who is sponsoring clinical trial NCT03355755?
This trial is sponsored by Ekso Bionics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03355755's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI